Skip to content
10-K

Annual Report

SIGNPATH PHARMA, INC.

0001096906-15-000373

← back to feed
Filed
Apr 9, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Mar 31, 2015 14.16M sh
Operating Cash Flow FY 2014 · Dec 31, 2013 −$1.62M
Current Liabilities FY 2014 · Dec 31, 2013 $421.63K
Current Assets FY 2014 · Dec 31, 2013 $1.24M
Total Assets FY 2014 · Dec 31, 2013 $1.24M
Sga Expense FY 2014 · Dec 31, 2013 $53.96K
Rd Expense FY 2014 · Dec 31, 2013 $841.5K
Net Income FY 2014 · Dec 31, 2013 −$1.96M
Operating Income FY 2014 · Dec 31, 2013 −$1.95M
Stockholders Equity restated FY 2014 · Dec 31, 2012 −$6.55M